Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China
Zhang, XY; Zeng, L; Li, YZ; Xu, QQ; Yang, HY; Lizaso, A; Mao, XR; Jin, RA; Zeng, Y; Li, QL; Wang, JB; Li, Y; Zhang, YC; Yang, N
Zhang, YC; Yang, N (corresponding author), Cent South Univ, Hunan Canc Hosp, Dept Med Oncol,Xiangya Sch Med, Lung Canc & Gastrointestinal Unit,Affiliated Canc, Changsha 410013, Peoples R China.; Zhang, YC; Yang, N (corresponding author), Univ South China, Grad Sch, Hengyang 421001, Hunan, Peoples R China.
CANCER IMMUNOLOGY IMMUNOTHERAPY, ; ():